Is government debt holding back SA’s medical device ecosystem?

The South African medical technology (MedTech) sector stands at a crossroads. While the national agenda is focused on industrialisation, localisation, and building a resilient healthcare system, a fundamental roadblock remains: the growing burden of unpaid public sector debt.

In a recent contribution to the Pharmaceutical and Medical Devices Action Lab Workshop, the South African Medical Device Industry Association (SAMED) delivered a blunt message: You cannot build a world-class manufacturing ecosystem on the backs of suppliers who are not being paid.

The sustainability crisis

At the heart of the discussion is the paradox of growth. The South African government is championing the MedTech Master Plan – a central framework aimed at coordinating action between industry and the state. However, the implementation of this plan is being undermined by systemic payment delays.

For local manufacturers and suppliers, these delays are not just an administrative nuisance; they are a threat to business sustainability. Persistent government debt:

• Erodes investor confidence: Capital avoids sectors where revenue is locked in bureaucratic bottlenecks.
• Disrupts supply continuity: Critical medical devices cannot reach patients if suppliers lack the cash flow to maintain inventory.
• Stifles localisation: Small to medium-sized local manufacturers, the very ones government wants to empower, are the most vulnerable to insolvency when payments are withheld.

Systemic barriers to progress

Beyond the issue of debt, SAMED highlighted in its LinkedIn post several structural challenges that continue to hamper the sector’s potential:

• Inefficient Procurement: Short procurement cycles discourage the long-term investment required for manufacturing plants and Research and Development.
• Regulatory Mismatch: Regulatory frameworks often fail to reflect the risk-based realities specific to medical devices, creating unnecessary hurdles for local innovation.
• Compliance Burdens: Current regulations often place a heavier burden on local manufacturers than on importers, inadvertently disadvantaging homegrown businesses.
• Disinvestment and Skills Loss: The cumulative effect of these challenges has led to a slow erosion of manufacturing capability, as skills and capital migrate to more stable markets.

A call for focused attention

While other health-related sectors have received significant government focus, the MedTech industry argues it has been secondary in industrial development discussions. There is, however, a silver lining. Discussions at the Action Lab revealed a “strong appetite” from both state and industry players to rebuild the sector.

The alignment is there. Government remains committed to manufacturing capability, skills development, and innovation. Industry is ready to participate. But as SAMED notes, this requires policy, financing, and procurement to be aligned with the operational realities of doing business.

The bottom line

If Gauteng and the broader South African economy are serious about healthcare resilience, the “not optional” task is to clear the debt owed to those who keep the hospitals running.

The opportunity for South Africa to become a regional MedTech powerhouse is real. But without addressing the financial foundation of the current ecosystem, the Master Plan remains a vision rather than a reality. The urgency for coordinated advocacy and swifter payment remains the industry’s loudest call to action.